ScholarLens Back to search
2019•CirculationRequires access

Abstract 11219: Evaluate The Incidence of Hypertension in Patients With Rheumatoid Arthritis Treated by Tnf Alpha Inhibitors

Hetavi Mahida, Ana Gubeladze, Dawn Calderon

Open publisher page 0 citations

Abstract

Introduction: Etanercept, Infliximab, Adalimumab and Certolizumab are the Tumor Necrosis factor alpha inhibitors (TNF inhibitors) used in the treatment of Rheumatoid arthritis(RA) Methods: Meta-ana...

About this research paper

What this paper is about

Introduction: Etanercept, Infliximab, Adalimumab and Certolizumab are the Tumor Necrosis factor alpha inhibitors (TNF inhibitors) used in the treatment of Rheumatoid arthritis(RA) Methods: Meta-ana...

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Introduction: Etanercept, Infliximab, Adalimumab and Certolizumab are the Tumor Necrosis factor alpha inhibitors (TNF inhibitors) used in the treatment of Rheumatoid arthritis(RA) Methods: Meta-ana...

Key concepts: Medicine, Rheumatoid arthritis, Incidence (geometry), Tumor necrosis factor alpha, Alpha (finance), Internal medicine, Arthritis, Pharmacology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Abstract 11219: Evaluate The Incidence of Hypertension in Patients With Rheumatoid Arthritis Treated by Tnf Alpha Inhibitors — Research Paper | ScholarLens